What to Ask Your Doctor If Your Fasting Glucose Is Borderline

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

A fasting glucose result between 100 and 125 mg/dL — sometimes called impaired fasting glucose, borderline fasting glucose, or prediabetes — is one of the most common findings on routine lab work. It is a signal the body is having some difficulty managing blood sugar after an overnight fast, but it does not mean type 2 diabetes has developed. For many people, it represents a window of opportunity: lifestyle changes made in this zone can be remarkably effective at preventing progression. This article explains what the numbers mean, why guidelines take them seriously, and what to discuss with your clinician.

What fasting glucose actually measures

A fasting blood glucose test measures the concentration of glucose (sugar) in your blood after you have not eaten or drunk anything except water for at least 8 hours — typically overnight. The result is reported in milligrams per deciliter (mg/dL).

In a person with normal glucose metabolism, the pancreas releases just enough insulin overnight to keep blood glucose at a stable, low level. Insulin is the hormone that allows cells to take up glucose from the bloodstream. When this system works smoothly, blood glucose stays below 100 mg/dL even after an extended fast.

When fasting glucose creeps above 100 mg/dL, it often reflects one of two underlying mechanisms:

• Insulin resistance. The liver and other tissues respond less effectively to insulin, so the liver continues producing glucose (gluconeogenesis) at a higher rate overnight than it should. The pancreas compensates by making more insulin — but eventually cannot keep up.
• Impaired insulin secretion. The pancreatic beta cells are producing less insulin than is needed to keep fasting glucose in the normal range.

Both of these processes often operate together, particularly in the context of excess body weight, physical inactivity, and metabolic syndrome.

A fasting glucose test is simpler and more reproducible than an oral glucose tolerance test (OGTT), which requires drinking a sugary solution and waiting two hours. The American Diabetes Association^[1] accepts fasting glucose, A1C, and OGTT as appropriate diagnostic tools for identifying prediabetes and diabetes.

What the numbers generally mean

Cleveland Clinic^[2] describes a healthy fasting blood sugar as 70–99 mg/dL. Results in the 100–125 mg/dL range place a person in the prediabetes zone.

Some additional context worth knowing:

• Where in the range matters. A fasting glucose of 102 mg/dL sits at the lower end of the prediabetes zone; a result of 122 mg/dL is very close to the diabetes threshold. The closer to 126, the more urgently your clinician will likely want to discuss next steps, including confirming with a second test or an A1C.
• Fasting glucose and A1C measure related but different things. Fasting glucose captures a snapshot of overnight glucose regulation. A1C reflects the average over 2–3 months. Some people will be in the prediabetes range on one test but normal on the other; your clinician may use both together for a fuller picture.
• Reproducibility. Because fasting glucose can vary from day to day, many guidelines suggest confirming a borderline result with a repeat test before drawing firm conclusions.

Why guidelines pay attention

The ADA Standards of Care in Diabetes — 2025^[3] provides the most current, comprehensive guidance on prediabetes and diabetes prevention. Key reasons borderline fasting glucose commands clinical attention:

• Prediabetes is common and largely unrecognized. Tens of millions of U.S. adults have prediabetes, and the majority are unaware of it.
• Progression risk is real but not inevitable. Without intervention, many people with prediabetes will develop type 2 diabetes within 5–10 years. But with lifestyle change, that progression can be substantially delayed or prevented.
• Lifestyle intervention is highly effective. The Diabetes Prevention Program (DPP) — a landmark clinical trial — found that intensive lifestyle intervention (approximately 7% weight loss, 150 minutes of moderate physical activity per week) reduced progression from prediabetes to type 2 diabetes by about 58% over 3 years.
• Cardiovascular risk begins before diabetes. Even at the prediabetes stage, insulin resistance and related metabolic abnormalities increase cardiovascular disease risk.
• Symptoms are usually absent. There are typically no symptoms at the prediabetes stage — routine screening catches it. This is why the ADA^[4] recommends screening for adults beginning at age 35, or earlier for those with risk factors.

Common drivers at the population level

Many of the same factors that drive A1C into the prediabetes range also cause fasting glucose to rise:

• Excess body weight, especially abdominal fat. Visceral (belly) fat secretes hormones and inflammatory signals that impair insulin sensitivity. The liver’s fasting glucose output is closely linked to central adiposity.
• Physical inactivity. Muscles are the primary site of glucose uptake when insulin signals them to act. Without regular activity, insulin resistance deepens over time.
• Diet pattern. High intake of refined carbohydrates, added sugars, sugary beverages, and ultra-processed foods stresses the glucose regulation system over time.
• Family history. Type 2 diabetes has a strong genetic component. Having a parent or sibling with type 2 diabetes meaningfully increases risk.
• Age. Insulin sensitivity tends to decline with age; the risk of prediabetes and type 2 diabetes rises accordingly.
• Sleep quality and quantity. Short or poor-quality sleep is associated with increased insulin resistance. Sleep apnea is particularly linked to disturbed glucose metabolism.
• Gestational diabetes history. Women who developed gestational diabetes during pregnancy have significantly higher lifetime risk of type 2 diabetes.
• Ancestry. South Asian, Hispanic/Latino, African American, Native American, and Pacific Islander ancestry groups have higher rates of prediabetes and type 2 diabetes at lower body weight thresholds.
• Polycystic ovary syndrome (PCOS). A condition strongly associated with insulin resistance and elevated fasting glucose.
• Certain medications. Corticosteroids, antipsychotics, and some other medications can raise fasting glucose.

What follow-up evaluation may be considered

When fasting glucose is borderline, clinicians typically think through:

• Confirming the result. A second fasting glucose, or an A1C test, helps confirm whether this represents a consistent pattern or a one-time fluctuation. Mayo Clinic^[4] and the ADA both recommend confirmatory testing.
• A1C measurement. Comparing fasting glucose with A1C gives a fuller picture of glucose regulation — fasting glucose reflects overnight insulin resistance, while A1C reflects 2–3 month average blood sugar.
• Full metabolic evaluation. This often includes blood pressure, cholesterol (lipid panel), kidney function (creatinine/eGFR), and sometimes liver enzymes — since prediabetes frequently occurs alongside other metabolic risk factors.
• Assessment for metabolic syndrome. Waist circumference, blood pressure, lipids, and glucose together determine whether metabolic syndrome is present.
• Discussion of diabetes prevention programs. The CDC recognizes the National DPP (Diabetes Prevention Program) — clinicians can refer eligible patients to in-person or online programs. The ADA 2025 Standards recommend referral for all people with prediabetes.
• Monitoring frequency. The ADA recommends annual glucose testing (fasting glucose or A1C) in people with prediabetes.
• Consideration of medication in some cases. For individuals at very high risk of progression (especially those with BMI ≥35, age under 60, or a history of gestational diabetes), the ADA notes that metformin may be considered alongside lifestyle intervention — but this is a clinical decision, not universal practice.

Lifestyle and prevention factors evidence supports

The evidence for lifestyle intervention in borderline fasting glucose is among the strongest in preventive medicine. The ADA, CDC^[5], and Cleveland Clinic^[2] consistently highlight:

• Modest weight loss. Losing 5–7% of body weight is associated with major risk reduction. For a 200-pound person, that is 10–14 pounds. This is the most impactful single lifestyle intervention for borderline fasting glucose.
• Regular physical activity. Aerobic exercise (brisk walking, cycling, swimming) done most days of the week improves insulin sensitivity in skeletal muscle. The DPP used 150 minutes per week as its target. Resistance training provides additional and independent benefit.
• Dietary quality. No single prediabetes diet has universal recommendation, but consistent themes include: more vegetables, legumes, whole grains, and lean protein; less refined carbohydrate, added sugar, and ultra-processed food. Reducing sugary beverages is among the highest-impact individual dietary changes.
• Reducing total carbohydrate load. For some people, moderating overall carbohydrate intake — not necessarily eliminating carbs, but replacing refined versions with higher-fiber alternatives — helps moderate fasting glucose.
• Improving sleep. For those with poor sleep quality or suspected sleep apnea, addressing these issues improves insulin sensitivity.
• Stress management. Chronic stress elevates cortisol, which raises blood glucose. Mindfulness-based practices, adequate sleep, and managing psychological stressors all support metabolic health.
• Consistency over time. Short-term changes matter, but sustained lifestyle modification is what prevents progression. Programs like the National DPP are structured over a year or more to support long-term habit change.

Many people with borderline fasting glucose are able to bring their numbers back into the normal range with sustained lifestyle change. Even those who do not fully normalize their fasting glucose typically see meaningful reduction in their risk of progressing to diabetes.

Questions to bring to your appointment

• What is my exact fasting glucose value, and how was the test taken — was it properly fasting?
• Should we confirm this finding with a second fasting glucose or add an A1C to get a 2–3 month average picture?
• Do I have other signs of prediabetes or metabolic syndrome — blood pressure, cholesterol, or weight — that we should address at the same time?
• What is my estimated risk of progressing to type 2 diabetes if I do not make changes?
• Am I a candidate for the Diabetes Prevention Program, and can you point me to a CDC-recognized program in my area or online?
• What would a meaningful weight loss goal look like for my situation?
• What types and amounts of physical activity would most benefit my blood sugar?
• Are there specific dietary changes you would prioritize for my fasting glucose pattern?
• Is there a role for checking my A1C, kidney function, and liver enzymes alongside this?
• Should I be screening for sleep apnea given my metabolic picture?
• Is there any reason to discuss medication options at this stage?
• What fasting glucose level would concern you enough to prompt an earlier or more urgent conversation?
• How often should I be rechecked going forward?

Red flags warranting prompter follow-up

Most people with borderline fasting glucose should schedule a follow-up within a few weeks. Contact your clinician sooner or promptly if you notice:

• Symptoms that suggest your blood sugar may have already crossed into the diabetes range: excessive thirst, frequent urination (especially at night), unexplained weight loss, blurred vision, or unusual fatigue
• A random (non-fasting) blood glucose reading above 200 mg/dL on any test
• Numbness, tingling, or burning in the hands or feet (can be an early sign of neuropathy)
• Wounds on the feet or legs that are slow to heal
• New or worsening symptoms that feel related to blood sugar changes

Key takeaways

• Fasting glucose between 100 and 125 mg/dL defines the prediabetes range (impaired fasting glucose) as established by the ADA and CDC.
• A single borderline result is often worth confirming with a repeat fasting glucose or an A1C before drawing firm conclusions.
• Prediabetes reflects underlying insulin resistance or impaired insulin secretion — both of which are strongly influenced by weight, activity level, and diet.
• Lifestyle intervention — especially 5–7% weight loss and 150 minutes of weekly aerobic activity — reduces progression to type 2 diabetes by approximately 58% in landmark clinical trials.
• The ADA 2025 Standards of Care support referral to CDC-recognized diabetes prevention programs for all people with prediabetes.
• Annual follow-up testing allows you and your clinician to track whether lifestyle changes are working or whether closer management is needed.

Disclaimer

This content is for general educational purposes only and is not medical advice. It does not create a doctor-patient relationship. Always talk to your licensed healthcare professional about your specific situation.

Post Views: 2